Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
School of Medicine; Department of Medicine, Division of Infectious Diseases and Immunology; Department of Family Medicine and Community Health
Eye Diseases | Immunity | Immunology of Infectious Disease | Infectious Disease | International Public Health | Ophthalmology | Virus Diseases
We report a case of probable Zaire Ebola virus–related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia. Uveitis, immune activation, and nonspecific increase in antibody titers developed during convalescence. This case highlights immune phenomena that could complicate management of Ebola virus disease–related uveitis during convalescence.
Ebola virus disease, uveitis, immune activation
Rights and Permissions
Emerging Infectious Diseases is published by the Centers for Disease Control and Prevention, a U.S. Government agency. Therefore, all materials published in Emerging Infectious Diseases are in the public domain and can be used without permission, per http://wwwnc.cdc.gov/eid/page/copyright-and-disclaimers.
DOI of Published Version
Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT III, Madoff LC, et al. Uveitis and systemic inflammatory markers in convalescent phase of Ebola virus disease. Emerg Infect Dis. 2016 Feb. doi:10.3201/eid2202.151416. Published ahead of print November 24, 2015. Link to article on publisher's website
Emerging Infectious Diseases
Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT, Madoff LC, Droms R, Hinkle D, Asdourian GK, Finberg RW, Stroher U, Uyeki TM, Cerón OM. (2016). Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Infectious Diseases and Immunology Publications. https://doi.org/10.3201/eid2202.151416. Retrieved from https://escholarship.umassmed.edu/infdis_pp/216